Coronary CT-FFR Software Market Report – Research, Industry Analysis Reports and Market Demands

Global Coronary CT-FFR Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

2 Company Profiles

3 Market Competition, by Players

3.1 Global Coronary CT-FFR Software Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Coronary CT-FFR Software by Company Revenue
- 3.2.2 Top 3 Coronary CT-FFR Software Players Market Share in 2025
- 3.2.3 Top 6 Coronary CT-FFR Software Players Market Share in 2025
3.3 Coronary CT-FFR Software Market: Overall Company Footprint Analysis
- 3.3.1 Coronary CT-FFR Software Market: Region Footprint
- 3.3.2 Coronary CT-FFR Software Market: Company Product Type Footprint
- 3.3.3 Coronary CT-FFR Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

4.1 Global Coronary CT-FFR Software Consumption Value and Market Share by Type (2021-2026)
4.2 Global Coronary CT-FFR Software Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

5.1 Global Coronary CT-FFR Software Consumption Value Market Share by Application (2021-2026)
5.2 Global Coronary CT-FFR Software Market Forecast by Application (2027-2032)

6 North America

6.1 North America Coronary CT-FFR Software Consumption Value by Type (2021-2032)
6.2 North America Coronary CT-FFR Software Market Size by Application (2021-2032)
6.3 North America Coronary CT-FFR Software Market Size by Country
- 6.3.1 North America Coronary CT-FFR Software Consumption Value by Country (2021-2032)
- 6.3.2 United States Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 6.3.3 Canada Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Coronary CT-FFR Software Market Size and Forecast (2021-2032)

7 Europe

7.1 Europe Coronary CT-FFR Software Consumption Value by Type (2021-2032)
7.2 Europe Coronary CT-FFR Software Consumption Value by Application (2021-2032)
7.3 Europe Coronary CT-FFR Software Market Size by Country
- 7.3.1 Europe Coronary CT-FFR Software Consumption Value by Country (2021-2032)
- 7.3.2 Germany Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 7.3.3 France Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 7.3.5 Russia Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 7.3.6 Italy Coronary CT-FFR Software Market Size and Forecast (2021-2032)

8 Asia-Pacific

8.1 Asia-Pacific Coronary CT-FFR Software Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Coronary CT-FFR Software Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Coronary CT-FFR Software Market Size by Region
- 8.3.1 Asia-Pacific Coronary CT-FFR Software Consumption Value by Region (2021-2032)
- 8.3.2 China Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 8.3.3 Japan Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 8.3.5 India Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 8.3.7 Australia Coronary CT-FFR Software Market Size and Forecast (2021-2032)

9 South America

9.1 South America Coronary CT-FFR Software Consumption Value by Type (2021-2032)
9.2 South America Coronary CT-FFR Software Consumption Value by Application (2021-2032)
9.3 South America Coronary CT-FFR Software Market Size by Country
- 9.3.1 South America Coronary CT-FFR Software Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Coronary CT-FFR Software Market Size and Forecast (2021-2032)

10 Middle East & Africa

10.1 Middle East & Africa Coronary CT-FFR Software Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Coronary CT-FFR Software Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Coronary CT-FFR Software Market Size by Country
- 10.3.1 Middle East & Africa Coronary CT-FFR Software Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Coronary CT-FFR Software Market Size and Forecast (2021-2032)
- 10.3.4 UAE Coronary CT-FFR Software Market Size and Forecast (2021-2032)

11 Market Dynamics

11.1 Coronary CT-FFR Software Market Drivers
11.2 Coronary CT-FFR Software Market Restraints
11.3 Coronary CT-FFR Software Trends Analysis
11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

12.1 Coronary CT-FFR Software Industry Chain
12.2 Coronary CT-FFR Software Upstream Analysis
12.3 Coronary CT-FFR Software Midstream Analysis
12.4 Coronary CT-FFR Software Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology
14.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Coronary CT-FFR Software market size was valued at US$ 192 million in 2025 and is forecast to a readjusted size of US$ 314 million by 2032 with a CAGR of 6.7% during review period.
Coronary CT-FFR (Fractional Flow Reserve derived from Computed Tomography) Software is a non-invasive AI-powered medical imaging software that computes fractional flow reserve values from routine coronary CT angiography (CCTA) scans. Using computational fluid dynamics or machine learning algorithms, the software simulates blood flow and pressure gradients across coronary artery stenoses to generate a quantitative FFR value (range 0-1) indicating the hemodynamic significance of a blockage (FFR ≤0.80 suggests ischemia-causing stenosis). This enables physicians to determine whether a coronary lesion is functionally significant without performing invasive catheterization.
The upstream segment includes AI algorithm developers, computational fluid dynamics engine providers, cloud computing infrastructure, and DICOM image processing toolkits. The midstream segment encompasses software development, regulatory approval (FDA, CE-MDR, NMPA), cloud-based platform deployment, and clinical validation performed by specialized AI medical imaging companies. CT-FFR software is categorized by computational method into CFD-based (computational fluid dynamics, processing time 1-4 hours), reduced-order algorithm (20-30 min), and machine learning-based (real-time); by deployment into cloud-based (HeartFlow, ~1-4 hours) and on-premise workstation (Siemens cFFR, 20 min); by clinical application into lesion-specific FFR, 3D vessel reconstruction and plaque analysis; and by end-user into hospitals, cardiac imaging centers, and outpatient clinics. The downstream segment serves interventional cardiologists, radiologists, and cardiac surgeons through software licensing, per-analysis fees, or subscription models.
The industry maintains gross margins between 70% and 85%, reflecting the scalable software-as-a-service economics and high-value nature of AI-driven non-invasive diagnostics.
The global coronary CT-FFR software market is experiencing rapid growth, driven by increasing adoption of non-invasive coronary physiology assessment, rising prevalence of coronary artery disease worldwide, and expanding reimbursement coverage across major healthcare systems. Large multicenter trials have demonstrated that CT-FFR can reduce unnecessary invasive catheterizations by up to 30% while improving diagnostic accuracy and lowering overall procedural costs. Consequently, major cardiology societies such as the ACC/AHA have incorporated CT-FFR into guideline recommendations for intermediate-risk coronary lesions.
A notable trend reshaping the market is the shift from CFD-based cloud processing to on-premise machine learning solutions. Traditional CT-FFR (HeartFlow) requires 1-4 hours of cloud-based processing, while newer reduced-order algorithm and machine learning-based solutions (Siemens cFFR, Toshiba CT-FFR) can compute results in 20-30 minutes directly on local workstations. This reduction in turnaround time is enabling same-day results and expanding clinical utility in outpatient settings, driving broader adoption across hospitals without cloud dependencies.
Another significant development is the expansion of FDA-approved clinical indications beyond lesion-specific FFR to include 3D vessel reconstruction, plaque characterization, and per-vessel FFR analysis. HeartFlow's Plaque Analysis received CPT Category I codes in 2024, with CY2026 reimbursement rates set at $1,021 per analysis, reflecting growing recognition of the clinical value of comprehensive CCTA-based physiological and anatomical assessment. The integration of AI-powered plaque quantification is enabling risk stratification beyond ischemia detection, supporting primary and secondary prevention strategies.
This report is a detailed and comprehensive analysis for global Coronary CT-FFR Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Coronary CT-FFR Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global Coronary CT-FFR Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Coronary CT-FFR Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Coronary CT-FFR Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Coronary CT-FFR Software
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Coronary CT-FFR Software market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include HeartFlow, Inc., Siemens Healthineers, Canon Medical Systems (Toshiba), GE Healthcare, Philips Healthcare, Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Shenzhen Ruixin Intelligent Medical Technology Co., Ltd., Shenzhen Yueying Technology Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Coronary CT-FFR Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cloud-Based Platform
On-Premise / Workstation-Based
Hybrid (Cloud + On-Premise)
Market segment by Turnaround Time
Real-Time (<5 minutes, ML-based)
Fast (20-30 minutes, Reduced-Order)
Extended (1-4 hours, CFD-based)
Market segment by Pricing Model
Per-Analysis Fee (Fee-for-Service)
Annual Software License
Perpetual License + Maintenance
Subscription (SaaS)
Market segment by Application
Hospitals & Cardiac Imaging Centers
Outpatient Clinics
Research Institutions
Market segment by players, this report covers
HeartFlow, Inc.
Siemens Healthineers
Canon Medical Systems (Toshiba)
GE Healthcare
Philips Healthcare
Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
Shenzhen Ruixin Intelligent Medical Technology Co., Ltd.
Shenzhen Yueying Technology Co., Ltd.
Shanghai United Imaging Intelligent Medical Technology Co., Ltd.
Lepu (Beijing) Medical Equipment Co., Ltd.
Hangzhou Atrui Technology Co., Ltd.
Pulse Imaging (Beijing) Medical Diagnostic Technology Co., Ltd.
Hangzhou Keya Medical Technology Co., Ltd.
Shanghai Pulse Medical Imaging Technology Co., Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Coronary CT-FFR Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Coronary CT-FFR Software, with revenue, gross margin, and global market share of Coronary CT-FFR Software from 2021 to 2026.
Chapter 3, the Coronary CT-FFR Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Coronary CT-FFR Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Coronary CT-FFR Software.
Chapter 13, to describe Coronary CT-FFR Software research findings and conclusion.

Buy now